#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Li-Fraumeni syndrome Blood iron increased Hereditary motor and sensory neuropathy Dedifferentiated liposarcoma Nephrotic syndrome Urethral valves Pemphigoid Primary mediastinal large B-cell lymphoma Chronic lymphocytic leukaemia Neuroendocrine cell hyperplasia of infancy Chondrosarcoma metastatic Renal disorder Hepatic angiosarcoma Shprintzen-Goldberg syndrome Endometrial cancer recurrent More trials…

    Learn about Rare Diseases

    Adrenogenital syndrome – Trials in Disease Basal cell naevus syndrome – Diagnostics Undifferentiated sarcoma – Basic Information Idiopathic pulmonary fibrosis – Life with Disease Hereditary optic atrophy Marfan’s syndrome – Treatment Mastocytosis – Basic Information Angiosarcoma non-metastatic – Treatment Systemic sclerosis pulmonary – Diagnostics Gastrointestinal stromal tumour – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    HAFNIUM OXIDE Galcanezumab Concizumab Opium, Standardized Powdered 1,3-BUTYLENE GLYCOL Carmustine Denosumab Fedratinib Pertechnetate (99Mtc) Sodium Warfarin Sodium Nefopam Mannitol Disodium Levofolinate Sodium Oxybate Xylitol A24110He Migalastat CITRIC ACID ANHYDROUS Vesleteplirsen Prasugrel Hydrobromide More therapies…

    Learn about Your Condition

    Femoral neck fracture Migraine with aura Acute on chronic liver failure Osteoarthritis Hepatitis B Thrombocytosis Coronary artery bypass Crohn's disease Adrenogenital syndrome Pelizaeus-Merzbacher disease Cholecystitis acute Appendicitis Gastric cancer Macular telangiectasia Haemodynamic instability More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of Raludotatug Deruxtecan for Patients with Platinum-resistant High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Malignant peritoneal neoplasm
    • Fallopian tube cancer
    • Ovarian cancer
    Investigated Drugs:
    • Raludotatug Deruxtecan
    • Topotecan
    • Doxorubicin Hydrochloride, Liposomal
    Czechia Finland France Germany Greece Italy +3

  • Study on the Safety and Efficacy of PF-06835375 and Diphenhydramine Hydrochloride for Adults with Moderate to Severe Primary Immune Thrombocytopenia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Immune thrombocytopenia
    Investigated Drugs:
    • Pf-06835375
    • Diphenhydramine Hydrochloride
    Czechia Hungary Poland

  • Study on the Effects of Amlodipine and Irbesartan in Patients with High Blood Pressure

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Irbesartan
    • Amlodipine
    Greece

  • Study of Zolbetuximab with Nab-Paclitaxel and Gemcitabine for Adults with Metastatic Pancreatic Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Zolbetuximab
    • Gemcitabine
    • Paclitaxel
    France Ireland Italy Spain

  • Study on the Long-Term Safety of Seladelpar for Patients with Primary Biliary Cholangitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Primary biliary cholangitis
    Investigated Drugs:
    • Seladelpar
    Austria Belgium Czechia France Germany Greece +6

  • Study Comparing Teclistamab with Daratumumab, Pomalidomide, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Bortezomib
    • Daratumumab
    • Dexamethasone
    Belgium Denmark France Germany Greece Italy +4
Previous Page
1 … 1,667 1,668 1,669 1,670 1,671 … 1,673
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!